• About Us
  • AKIP
  • Live TV
  • Our Programs
  • Latest News
    • Church News
    • Politics
    • Foreign News
    • Security
  • Airtime
  • From GM’s Desk
  • Church of Nigeria
  • Contact
Facebook Twitter Instagram
  • AKIP
  • From GM’s Desk
  • Live TV
Facebook Twitter Instagram
Advent Cable Network Nigeria Advent Cable Network Nigeria
  • Home
  • About Us
  • AKIP
  • Latest News
    • Church News
    • Politics
    • Security
    • Foreign News
    • Sport
  • Live TV
  • Our Programs
  • Airtime
  • Church of Nigeria
  • Contact
Donate
Advent Cable Network Nigeria Advent Cable Network Nigeria
Home»Health»WHO to resume trial of hydroxychloroquine on COVID-19
Health

WHO to resume trial of hydroxychloroquine on COVID-19

ACNN TVBy ACNN TVJune 4, 2020No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email WhatsApp
Share
Facebook Twitter LinkedIn Pinterest Email WhatsApp

The World Health Organisation (WHO) will resume its trial of hydroxychloroquine for the treatment of coronavirus (COVID-19) patients, its Director-General, Dr Tedros Ghebreyesus, says.
Ghebreyesus, who stated this on the official twitter account of the UN health agency, said the hydroxychloroquine section of WHO’s Solidarity Trial can resume after being paused temporarily on May 25.
The trial’s Data Safety and Monitoring Committee had halted the study as a precaution in response to safety concerns raised by an observational study published in the Lancet.
Ghebreyesus said the Data Safety Monitoring Board’s review had been completed.
“Last week, the Executive Group of the Solidarity Trial decided to implement a temporary pause of the hydroxychloroquine arm of the trial, because of concerns raised about the safety of the drug.
“This decision was taken as a precaution while the safety data were reviewed. The Data Safety and Monitoring Committee of the Solidarity Trial has been reviewing the data.
“On the basis of available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.
“The Executive Group received this recommendation and endorsed the continuation of all arms of the Solidarity Trial, including hydroxychloroquine.
“The Executive Group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm,’’ he said.

The WHO director-general said the Data Safety and Monitoring Committee would continue to closely monitor the safety of all therapeutics being tested in the Solidarity Trial.
“So far, more than 3,500 patients have been recruited in 35 countries.
“WHO is committed to accelerating the development of effective therapeutics, vaccines and diagnostics as part of our commitment to serving the world with science, solutions and solidarity,’’ he said.
Meanwhile, Nigeria on May 27 declared that it would continue with hydroxychloroquine clinical trials on COVID-19 patients.
Prof. Mojisola Adeyeye, the Director-General of National Agency for Food and Drug Administration and Control (NAFDAC), said the country would continue with the drug.
She said this would be in spite of the initial warning by WHO to discontinue using it.
“I do not know the data they’re looking at, whether it’s from the Caucasian population or from the African population.
“If the data they’re looking at, and the reason for suspending the trials, is from the Caucasian population, then it may be justified.
“But I don’t think we have data from the African population yet, because our genetic make-up is different.
“If medical doctors, research scientists, pharmacists and herbal experts work together, we should conclude the clinical trial in three to four months.
“The narrative may change afterwards. But for now, we believe in hydroxychloroquine,” she said.
(NAN)

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email WhatsApp

Related Posts

Federal Govt States Reasons Tuberculosis Kills Patients Silently

March 28, 2023

10 Things to Know About Hypertension

March 23, 2023

Taking Medication as a Child of God || By Bishop Unuigbe

March 21, 2023
Add A Comment

Leave A Reply Cancel Reply

Recent Posts

Roman Catholic Priest Wins Benue State Gubernatorial Election

March 20, 2023

CBN Finally Obeys Supreme Court Order Over Old Naira Notes

March 13, 2023

Words of Caution on the 2023 Nigerian Presdential Election – Bishop Adebogun

March 1, 2023

Primate Ndukuba Encourage Nigerians, Congratulate All Winners, as INEC Announces Presidential Election Winner

March 1, 2023

Court Of Appeal Justice, Chancellor of Egba Anglican Diocese, Lokulo-Sodipe Slumps And Dies In Court

February 27, 2023
Advent Cable Network Nigeria

ACNNTV is the Televangelism arm of the Church of Nigeria (Anglican Communion) with focus to keep the orthodox faith alive through development of inspiring and life changing broadcast products.

Facebook Twitter Instagram
Quick Links
  • About Us
  • AKIP
  • Board of Management
  • Contact
  • Privacy Policy
Quick Links
  • Our Programs
  • Program Rates
  • From GM’s Desk
  • Live TV

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

© 2023 Anglican Cable Network Nigeria,Abuja. Designed by Dominion Web.

Type above and press Enter to search. Press Esc to cancel.